Michael Ferguson
Corporate Officer/Principal presso ABIVAX
Posizioni attive di Michael Ferguson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ABIVAX | Corporate Officer/Principal | 18/04/2023 | - |
Storia della carriera di Michael Ferguson
Precedenti posizioni note di Michael Ferguson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/01/2019 | 01/05/2022 |
Formazione di Michael Ferguson
| The Pennsylvania State University | Masters Business Admin |
| St. Joseph's University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Francia | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABIVAX | Health Technology |
| Aziende private | 1 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
- Borsa valori
- Insiders
- Michael Ferguson
- Esperienza
